Nolan Sean P.
Insider CIK 1569926 · ITMN Executive VP & CBO · AQXP Director · AVXS President & CEO, Director · TSHA Chief Executive Officer, Director · VTR Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VTR Ventas, Inc. | A Award | 2026-05-13 | 2026-05-15 | 2,047 | $90.35 | $184.9K | 26,181 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | S Sale | 2026-01-26 | 2026-01-27 | 41,312 | $4.61 | $190.4K | 2,908,257 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | S Sale | 2026-01-23 | 2026-01-27 | 136,789 | $4.75 | $649.7K | 2,949,569 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | A Award deriv | 2026-01-12 | 2026-01-14 | 648,000 | — | $0 | 648,000 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | A Award | 2026-01-12 | 2026-01-14 | 1,008,000 | — | $0 | 3,086,358 | SEC↗ |
| VTR Ventas, Inc. | A Award | 2025-05-13 | 2025-05-15 | 2,882 | $64.18 | $185.0K | 24,134 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | A Award deriv | 2025-01-02 | 2025-01-03 | 892,500 | — | $0 | 892,500 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | A Award | 2025-01-02 | 2025-01-03 | 892,500 | — | $0 | 2,078,358 | SEC↗ |
| VTR Ventas, Inc. | A Award | 2024-05-14 | 2024-05-16 | 3,648 | $47.96 | $175.0K | 21,252 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | A Award deriv | 2024-01-02 | 2024-01-04 | 1,184,688 | — | $0 | 1,184,688 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | A Award | 2024-01-02 | 2024-01-04 | 1,184,688 | — | $0 | 1,185,858 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | A Award deriv | 2023-12-14 | 2023-12-18 | 466,550 | — | $0 | 466,550 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | P Buy | 2023-08-16 | 2023-08-16 | 444,444 | $0.90 | $400.0K | 1,535,545 | SEC↗ |
| VTR Ventas, Inc. | A Award | 2023-05-16 | 2023-05-18 | 3,835 | $45.63 | $175.0K | 17,604 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | A Award deriv | 2022-12-30 | 2023-01-04 | 1,106,131 | — | $0 | 1,106,131 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | A Award deriv | 2022-06-17 | 2022-06-22 | 15,500 | — | $0 | 15,500 | SEC↗ |
| VTR Ventas, Inc. | A Award | 2022-04-27 | 2022-04-29 | 3,056 | $57.25 | $175.0K | 13,769 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | A Award deriv | 2021-06-17 | 2021-06-21 | 15,500 | — | $0 | 15,500 | SEC↗ |
| VTR Ventas, Inc. | A Award | 2021-05-25 | 2021-05-27 | 3,158 | — | $0 | 10,713 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | P Buy | 2021-05-20 | 2021-05-24 | 1,170 | $22.35 | $26.1K | 1,170 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | C Conversion deriv | 2020-09-28 | 2020-09-30 | 1,470 | — | $0 | 0 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | C Conversion deriv | 2020-09-28 | 2020-09-30 | 1,000,000 | — | $0 | 0 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | C Conversion | 2020-09-28 | 2020-09-30 | 1,089,500 | — | $0 | 1,089,500 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | C Conversion | 2020-09-28 | 2020-09-30 | 1,601 | — | $0 | 1,091,101 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | A Award deriv | 2020-09-23 | 2020-09-25 | 31,000 | — | $0 | 31,000 | SEC↗ |
| VTR Ventas, Inc. | A Award | 2020-05-18 | 2020-05-20 | 5,424 | — | $0 | 7,555 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | A Award deriv | 2020-05-05 | 2020-05-07 | 25,000 | — | $0 | 25,000 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | A Award deriv | 2019-10-10 | 2019-10-15 | 22,000 | — | $0 | 22,000 | SEC↗ |
| VTR Ventas, Inc. | A Award | 2019-07-26 | 2019-07-29 | 2,131 | $67.03 | $142.8K | 2,131 | SEC↗ |
| AVXS AveXis, Inc. | D To issuer deriv | 2018-05-15 | 2018-05-15 | 728,300 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | D To issuer deriv | 2018-05-15 | 2018-05-15 | 96,000 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | D To issuer deriv | 2018-05-15 | 2018-05-15 | 44,000 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | D To issuer deriv | 2018-05-15 | 2018-05-15 | 110,000 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | D To issuer | 2018-05-15 | 2018-05-15 | 11,000 | — | $0 | 0 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | A Award deriv | 2018-05-07 | 2018-05-09 | 15,000 | — | $0 | 15,000 | SEC↗ |
| AVXS AveXis, Inc. | A Award deriv | 2018-03-13 | 2018-03-27 | 44,000 | — | $0 | 44,000 | SEC↗ |
| AVXS AveXis, Inc. | A Award | 2018-03-13 | 2018-03-27 | 11,000 | — | $0 | 11,000 | SEC↗ |
| AVXS AveXis, Inc. | M Exercise deriv | 2018-03-07 | 2018-03-09 | 10,000 | — | $0 | 728,300 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2018-03-07 | 2018-03-09 | 600 | $130.78 | $78.5K | 1,100 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2018-03-07 | 2018-03-09 | 1,100 | $131.86 | $145.0K | 0 | SEC↗ |
| AVXS AveXis, Inc. | M Exercise | 2018-03-07 | 2018-03-09 | 10,000 | $15.94 | $159.4K | 10,000 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2018-03-07 | 2018-03-09 | 400 | $126.65 | $50.7K | 9,600 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2018-03-07 | 2018-03-09 | 700 | $127.65 | $89.4K | 8,900 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2018-03-07 | 2018-03-09 | 2,400 | $128.65 | $308.8K | 6,500 | SEC↗ |
| AVXS AveXis, Inc. | S Sale | 2018-03-07 | 2018-03-09 | 4,800 | $129.66 | $622.4K | 1,700 | SEC↗ |
| AVXS AveXis, Inc. | A Award deriv | 2017-05-10 | 2017-05-12 | 96,000 | — | $0 | 96,000 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | A Award deriv | 2017-05-08 | 2017-05-10 | 9,000 | — | $0 | 9,000 | SEC↗ |
| AVXS AveXis, Inc. | A Award deriv | 2016-06-20 | 2016-06-22 | 110,000 | — | $0 | 110,000 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | A Award deriv | 2016-05-09 | 2016-05-11 | 7,500 | — | $0 | 7,500 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | A Award deriv | 2015-03-12 | 2015-03-16 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ITMN INTERMUNE INC | D To issuer deriv | 2014-09-29 | 2014-10-01 | 20,000 | — | $0 | 0 | SEC↗ |
| ITMN INTERMUNE INC | D To issuer deriv | 2014-09-29 | 2014-10-01 | 22,500 | — | $0 | 0 | SEC↗ |
| ITMN INTERMUNE INC | D To issuer deriv | 2014-09-29 | 2014-10-01 | 6,800 | — | $0 | 0 | SEC↗ |
| ITMN INTERMUNE INC | D To issuer deriv | 2014-09-29 | 2014-10-01 | 141,000 | — | $0 | 0 | SEC↗ |
| ITMN INTERMUNE INC | D To issuer deriv | 2014-09-29 | 2014-10-01 | 7,500 | — | $0 | 0 | SEC↗ |
| ITMN INTERMUNE INC | D To issuer | 2014-09-29 | 2014-10-01 | 56,400 | $74.00 | $4.17M | 0 | SEC↗ |
| ITMN INTERMUNE INC | U Tender | 2014-09-29 | 2014-10-01 | 9,271 | $74.00 | $686.1K | 56,400 | SEC↗ |
| ITMN INTERMUNE INC | M Exercise deriv | 2014-08-13 | 2014-08-14 | 17,000 | — | $0 | 141,000 | SEC↗ |
| ITMN INTERMUNE INC | M Exercise | 2014-08-13 | 2014-08-14 | 17,000 | $9.29 | $157.9K | 82,671 | SEC↗ |
| ITMN INTERMUNE INC | S Sale | 2014-08-13 | 2014-08-14 | 17,000 | $50.00 | $850.0K | 65,671 | SEC↗ |
| ITMN INTERMUNE INC | M Exercise deriv | 2014-06-18 | 2014-06-20 | 10,000 | — | $0 | 158,000 | SEC↗ |
| ITMN INTERMUNE INC | S Sale | 2014-06-18 | 2014-06-20 | 10,000 | $47.10 | $471.0K | 65,671 | SEC↗ |
| ITMN INTERMUNE INC | M Exercise | 2014-06-18 | 2014-06-20 | 10,000 | $9.29 | $92.9K | 75,671 | SEC↗ |
| ITMN INTERMUNE INC | D To issuer deriv | 2014-06-13 | 2014-06-13 | 10,000 | — | $0 | 168,000 | SEC↗ |
| ITMN INTERMUNE INC | M Exercise deriv | 2014-06-13 | 2014-06-18 | 10,000 | — | $0 | 168,000 | SEC↗ |
| ITMN INTERMUNE INC | M Exercise | 2014-06-13 | 2014-06-13 | 10,000 | $9.29 | $92.9K | 75,671 | SEC↗ |
| ITMN INTERMUNE INC | S Sale | 2014-06-13 | 2014-06-13 | 10,000 | $44.35 | $443.5K | 65,671 | SEC↗ |
| ITMN INTERMUNE INC | M Exercise | 2014-06-13 | 2014-06-18 | 10,000 | $9.29 | $92.9K | 75,671 | SEC↗ |
| ITMN INTERMUNE INC | S Sale | 2014-06-13 | 2014-06-18 | 10,000 | $44.35 | $443.5K | 65,671 | SEC↗ |
| ITMN INTERMUNE INC | D To issuer deriv | 2014-06-06 | 2014-06-13 | 10,000 | — | $0 | 178,000 | SEC↗ |
| ITMN INTERMUNE INC | M Exercise deriv | 2014-06-06 | 2014-06-18 | 10,000 | — | $0 | 178,000 | SEC↗ |
| ITMN INTERMUNE INC | M Exercise | 2014-06-06 | 2014-06-13 | 10,000 | $9.29 | $92.9K | 75,671 | SEC↗ |
| ITMN INTERMUNE INC | S Sale | 2014-06-06 | 2014-06-13 | 10,000 | $41.25 | $412.5K | 65,671 | SEC↗ |
| ITMN INTERMUNE INC | S Sale | 2014-06-06 | 2014-06-18 | 10,000 | $41.25 | $412.5K | 65,671 | SEC↗ |
| ITMN INTERMUNE INC | M Exercise | 2014-06-06 | 2014-06-18 | 10,000 | $9.29 | $92.9K | 75,671 | SEC↗ |
| ITMN INTERMUNE INC | S Sale | 2014-06-03 | 2014-06-05 | 385 | $38.78 | $14.9K | 65,671 | SEC↗ |
| ITMN INTERMUNE INC | M Exercise deriv | 2014-05-30 | 2014-06-03 | 1,000 | — | $0 | 3,000 | SEC↗ |
| ITMN INTERMUNE INC | M Exercise | 2014-05-30 | 2014-06-03 | 1,000 | — | $0 | 66,056 | SEC↗ |
| ITMN INTERMUNE INC | A Award deriv | 2014-05-29 | 2014-06-03 | 22,500 | — | $0 | 22,500 | SEC↗ |
| ITMN INTERMUNE INC | A Award deriv | 2014-05-29 | 2014-06-03 | 4,500 | — | $0 | 4,500 | SEC↗ |
| ITMN INTERMUNE INC | A Award deriv | 2014-05-29 | 2014-06-03 | 6,800 | — | $0 | 6,800 | SEC↗ |
| ITMN INTERMUNE INC | S Sale | 2014-05-19 | 2014-05-21 | 7,500 | $39.50 | $296.3K | 65,056 | SEC↗ |
| ITMN INTERMUNE INC | S Sale | 2014-05-08 | 2014-05-12 | 2,644 | $35.85 | $94.8K | 72,556 | SEC↗ |
| ITMN INTERMUNE INC | A Award deriv | 2013-05-30 | 2013-06-03 | 4,000 | — | $0 | 4,000 | SEC↗ |
| ITMN INTERMUNE INC | A Award deriv | 2013-05-30 | 2013-06-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ITMN INTERMUNE INC | A Award deriv | 2013-03-07 | 2013-03-11 | 188,000 | — | $0 | 188,000 | SEC↗ |
| ITMN INTERMUNE INC | A Award | 2013-03-07 | 2013-03-11 | 75,200 | — | $0 | 75,200 | SEC↗ |